DNLI (denalitherapeutics.com) Company Profit
Denali Therapeutics (DNLI) operating results reflect the dynamics of a biotech firm uniting leading neurobiologists to combat brain degeneration. However, rising R&D costs and a lack of sales are temporarily hindering scaling, while -0.51 shapes the current metric. Development is based on creating blood-brain barrier crossing systems through strategic alliances with pharmaceutical behemoths.
Analytical breakdowns and data insights for company Denali Therapeutics Inc. (DNLI)
- stock value and consensus price forecast:
- business market valuation indicators:
- book capitalization information:
- debt burden and liquidity indicators:
Total Debt to Capital Denali Therapeutics|DNLI - Long-Term Debt to Equity|Short-Term Debt to Equity Denali|DNLI - Company Aggregate Debts|Debts to Net Assets Denali Corp|DNLI - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Denali Therapeutics|Intermediate Liquidity Ratio denalitherapeutics.com
- company profitability and valuation multiples indicators:
Fundamental valuation:DNLI - Denali Corp
This indicator objectively measures the equity value of net income on a daily basis, allowing for an assessment of long-term expansion potential and the risk of overpayment when reaching historical highs. For Denali Therapeutics (DNLI), the company's reported earnings reflect the monetization efficiency of its unique blood-brain barrier crossing platform, determining the financial stability of the foundation for treating neurodegenerative diseases.
Key competitors
Company Net Income Biogen Idec (BIIB)|NBIX (Neurocrine Biosciences) - Net Profit|Company Profit RGC (regencellbioscience.com)|Net Profit AXSM|ACAD - Company Net Income|Company Net Income Xenon Pharmaceuticals Inc XENE|VKTX: Company Profit|Supernus Pharmaceuticals - Net Profit|CPRX - Net Profit|Harmony Biosciences Holdings, Inc. (HRMY) - Company Net Income|BHVN (Biohaven Ltd) - Company Net Income|AMLX (Amylyx) - Net Profit|Trevi Corp (TRVI) - Net Financial Result|Net Income PRAX (Praxis Precision Medicines)|AVXL (anavex.com) - Final Profit|CeriBell - Net Income|Profit After Payment of Taxes PRTA (Prothena Corp)|Alector Therapeutics - Net Profit|Final Profit ANNX (Annexon Biosciences Inc.)|OMER: Net Profit|Company Net Income neurogene.com (NGNE)|Company Net Income AC Immune SA|VYGR: Final Profit|Net Profit NMRA|Net Profit Scilex Holding Company, Inc. (SCLX)|Company Net Income Tevogen Bio Holdings TVGN|ACOG (Alpha Cognition Inc) - Profit After Tax|Cognition Therapeutics - Net Profit|Company Net Income Inhibikase Therapeutics Inc|SAVA (Cassava) - Net Income|Assertio (ASRT) - Net Profit|Net Income COYA|VTGN (VistaGen Therapeutics Inc) - Profit After Payment of Taxes|Net Profit OVID|Net Financial Result Acumen Pharmaceuticals Inc.|Net Profit CRVO (CervoMed Inc)|ATHE - Net Income|CLNN - Company Net Income|Net Financial Result PepGen Inc. PEPG|JUNS: Net Profit|Company Profit RLMD|Company Net Income Annovis Bio Corp|Company Profit GRCE (Grace Tx)|Company Net Income Firefly Neuroscience, Inc (AIFF)|Company Net Income KLTO (anewmeds.com)|Net Profit NRSN (NeuroSense Therapeutics Ltd.)|Net Financial Result Reviva Pharmaceuticals Holdings Inc. (RVPH)|MTVA - Company Net Income|NRXS (NeurAxis Inc) - Company Profit|HSDT: Net Profit|Company Net Income Passage Bio (PASG)|Net Income NEUP|Net Profit Minerva Neurosciences Inc|Company Net Income Athira (ATHA)|ADXN (Addex) - Final Profit|Company Net Income Alzamend Neuro ALZN|Cyclerion Therapeutics Inc. (CYCN) - Company Net Income|Protagenic - Net Profit|KTTA (Pasithea Therapeutics) - Company Profit|CRGT: Net Profit|Company Net Income Avenue Therapeutics Inc (ATXI)|Company Net Income Brainstorm Cell|Company Profit CARA (caratherapeutics.com)|Net Profit CHRO|Net Profit eliemtx.com (ELYM)|Company Net Income Intra-Cellular Therapies, Inc. ITCI|Longboard - Company Net Income|Marinus Pharmaceuticals - Net Profit|Net Financial Result nkgenbiotech.com NKGN|NRBO (NeuroBo Pharmaceuticals, Inc.) - Net Income|Sage Therapeutics Inc. - Final Profit|Net Income SNPX|TRVN (Trevena Inc) - Profit After Payment of Taxes|Net Profit VIGL|WENA (Anew Medical Inc.) - Final Profit|Net Profit CERE (Cerevel Therapeutics, Inc.)